object
author
investig
ideal
acoust
condit
clinic
scanner
customprogram
ultrasound
us
cavitationmedi
flow
augment
preclin
model
appli
condit
firstinhuman
studi
test
hypothesi
contrast
us
increas
limb
perfus
normal
subject
patient
peripher
arteri
diseas
pad
background
usinduc
cavit
microbubbl
contrast
agent
augment
tissu
perfus
convect
shear
secondari
purinerg
signal
mediat
releas
endogen
vasodil
method
mice
unilater
exposur
proxim
hindlimb
therapeut
us
mhz
mechan
index
perform
min
intraven
inject
lipid
microbubbl
us
vari
accord
line
densiti
line
puls
durat
microvascular
perfus
evalu
us
perfus
imag
vivo
adenosin
triphosph
atp
releas
assess
use
vivo
optic
imag
optim
paramet
use
healthi
volunt
patient
pad
calf
us
alon
combin
intraven
microbubbl
contrast
infus
perform
min
result
mice
flow
augment
usexpos
limb
acoust
condit
lowest
line
densiti
stepwis
increas
perfus
longer
versu
shorter
puls
durat
higher
line
densiti
blood
flow
consist
increas
usexpos
limb
irrespect
puls
durat
high
line
densiti
long
puls
durat
result
greatest
releas
atp
cavit
zone
applic
optim
condit
human
togeth
intraven
contrast
increas
calf
muscl
blood
flow
healthi
subject
patient
pad
wherea
us
alon
effect
conclus
us
microbubbl
use
optim
acoust
environ
increas
perfus
limb
skelet
muscl
rais
possibl
therapi
patient
pad
augment
limb
perfus
contrast
ultrasound
j
coll
cardiol
img
atp
adenosin
triphosph
ceu
contrastenhanc
ultrasound
mb
microbubbl
mi
mechan
index
pad
peripher
arteri
diseas
us
ultrasound
mason
et
al
u
ltrasound
us
wide
varieti
biolog
effect
abil
us
increas
tissu
blood
flow
nontherm
manner
occur
part
acoust
driven
vascular
shear
convect
motion
therebi
initi
endogen
endothelialdepend
vasodilatori
pathway
encapsul
microbubbl
mb
contrast
agent
expos
us
undergo
volumetr
oscil
call
cavit
produc
high
local
shear
forc
accordingli
mb
inerti
cavit
destruct
increas
tissu
perfus
much
greater
extent
us
alon
molecular
mechan
contrastenhanc
us
ceu
augment
flow
releas
adenosin
triphosph
atp
subsequ
purinerg
signal
lead
product
nitric
oxid
prostaglandin
adenosin
therapeut
potenti
mb
cavit
use
us
frequenc
pressur
within
diagnost
rang
demonstr
anim
model
acut
myocardi
infarct
peripher
arteri
diseas
pad
tissu
ischemia
could
either
fulli
partial
revers
observ
benefici
effect
last
long
complet
ceu
thought
repres
sustain
atp
releas
occur
acut
cellular
micropor
also
purinerg
channel
activ
studi
investig
limb
flow
augment
atp
releas
mice
could
optim
modifi
us
transmit
set
line
densiti
puls
durat
influenc
pressur
shear
condit
mb
inerti
cavit
appli
knowledg
firstinhuman
trial
test
hypothesi
augment
limb
blood
flow
could
achiev
ceu
perform
shortdur
mb
cavit
protocol
normal
human
subject
patient
pad
also
test
whether
flow
augment
occur
remot
usexpos
region
base
potenti
cavit
increas
system
concentr
atp
vasodil
shown
produc
detect
chang
perfus
mb
infus
rate
min
timeintens
data
frame
rate
hz
acquir
highpow
mi
sequenc
fit
function
bt
use
nonlinear
leastsquar
regress
intens
time
plateau
intens
repres
rel
microvascular
blood
volum
rate
constant
b
microvascular
flux
rate
microvascular
blood
flow
quantifi
product
b
differ
assess
use
unpair
student
ttest
use
mannwhitney
u
test
data
determin
nonnorm
distribut
use
dagostino
pearson
omnibu
test
comparison
within
group
ie
chang
perfus
baselin
evalu
use
pair
student
ttest
wilcoxon
test
bonferroni
correct
use
comparison
condit
differ
consid
signific
p
program
us
field
calibr
hydrophon
measur
demonstr
clinic
imag
probe
could
achiev
peak
neg
acoust
pressur
rang
kpa
mpa
mi
larg
independ
puls
length
output
condit
set
achiev
peak
neg
acoust
pressur
mpa
approxim
previous
use
augment
tissu
flow
mice
computersimul
field
assess
differ
program
line
densiti
show
excel
agreement
hydrophon
data
beam
width
measur
within
agreement
figur
nontherm
bioeffect
produc
us
shear
forc
occur
convect
motion
microstream
shock
wave
format
thought
import
therapeut
augment
tissu
perfus
effect
us
microvascular
resist
amplifi
severalfold
presenc
mb
contrast
agent
includ
approv
diagnost
use
human
studi
test
vascular
effect
differ
acoust
set
within
regulatori
pressur
limit
implement
clinic
scanner
test
efficaci
human
show
fold
increas
limb
blood
flow
achiev
normal
subject
patient
pad
preclin
studi
focus
entir
mb
cavit
previous
demonstr
limb
flow
augment
much
less
us
alon
compar
ceu
despit
duti
factor
durat
us
exposur
sever
order
magnitud
higher
also
known
limb
flow
augment
produc
inerti
cavit
increas
acoust
pressur
limit
clinic
scanner
without
caus
advers
bioeffect
accordingli
examin
line
densiti
current
studi
intend
find
balanc
avoid
betweenlin
gap
low
line
densiti
result
situat
mb
expos
high
acoust
pressur
avoid
mb
cavit
neighbor
line
high
line
densiti
would
destroy
mb
exposur
intend
high
acoust
pressur
figur
puls
durat
also
studi
base
knowledg
mb
undergo
sustain
cavit
long
puls
probabl
continu
acoust
activ
free
ga
releas
shell
boundari
long
puls
durat
compar
continu
segment
scheme
previou
studi
perform
latter
yet
sustain
cavit
without
cycl
interrupt
may
vivo
studi
indic
releas
atp
key
process
ceumedi
flow
augment
central
illustr
act
secondarili
varieti
vasodil
includ
nitric
oxid
adenosin
prostanoid
current
studi
set
reliabl
increas
flow
also
produc
greatest
atp
signal
usexpos
site
howev
find
also
indic
atp
signal
proport
relat
flow
augment
phenomenon
could
explain
exist
threshold
concentr
atp
increas
flow
purineg
signal
like
domin
atp
transient
releas
shear
forc
red
blood
cell
us
also
signal
optic
imag
unlik
intravascular
atp
mediat
vasodil
also
reflect
interstiti
atp
produc
neurogen
vasoconstrict
first
evid
limb
blood
flow
human
could
increas
mb
cavit
describ
studi
ceu
use
assess
skelet
find
remark
small
volum
calf
expos
us
unlik
murin
model
pad
min
ceu
exposur
revers
ischemia
h
durat
effect
limit
human
find
like
reflect
major
differ
proport
limb
expos
us
believ
therapeut
effect
augment
us
program
usmb
n
contralater
n
exist
system
use
spatial
data
cavit
studi
design
elev
space
although
studi
perform
patient
primarili
intermitt
claudic
implic
result
therapeut
ceu
could
use
sever
diseas
acceler
wound
heal
limb
salvag
critic
limbthreaten
ischemia
requir
delay
definit
therapi
success
implement
strategi
requir
investig
protocol
chang
could
produc
longer
durat
effect
accord
murin
data
may
possibl
greater
spatial
extent
cavit
mb
agent
circul
long
durat
clearanc
therebi
increas
potenti
durat
therapi
cavit
mb
also
explor
abil
acceler
clot
lysi
acut
mi
peripher
thrombot
event
abil
increas
tissu
perfus
independ
sonothrombolysi
need
consid
examin
efficaci
therapi
use
transient
open
bloodbrain
barrier
drug
deliveri
deliv
therapeut
rna
directli
target
cell
sonopor
rescu
tissu
flow
set
microvascular
obstruct
recan
acut
thrombos
epicardi
coronari
cranial
arteri
sonothrombolysi
decreas
brain
betaamyloid
accumul
cognit
dysfunct
patient
alzheim
diseas
recent
earli
clinic
trial
use
utmc
treat
glioblastoma
alzheim
diseas
supplement
primari
stent
acut
myocardi
infarct
report
issu
ijacc
mason
et
al
describ
anoth
therapeut
applic
utmc
ultrasoundinduc
destruct
inerti
cavit
microbubbl
augment
skelet
muscl
blood
flow
treatment
limb
ischemia
previou
studi
demonstr
utmc
caus
vasodil
releas
nitric
oxid
prostanoid
adenosin
possibl
via
increas
adenosin
triphosph
atp
releas
studi
mason
et
al
take
next
clinic
translat
step
demonstr
utmc
caus
transient
skelet
muscl
hyperemia
human
subject
without
peripher
arteri
diseas
illustr
beauti
ultrasound
theranost
ultrasound
microbubbl
use
provid
therapi
skelet
muscl
well
imag
hyperem
effect
therapi
fundament
question
pose
current
studi
studi
utmc
therapeut
best
acoust
regim
achiev
studi
highlight
complex
paramet
space
must
deal
order
intellig
select
acoust
condit
maxim
desir
effect
utmcmedi
flow
augment
although
need
understand
complic
interrelationship
may
challeng
data
also
suggest
desir
result
achiev
use
variou
ultrasound
set
crisscross
highway
one
way
get
destin
regard
freedom
oper
respect
defin
optim
acoust
regimen
serv
clinic
translat
good
thing
one
acoust
recip
may
abl
induc
hindlimb
flow
augment
highlight
need
probe
deepli
identifi
govern
biophys
principl
drive
phenomenon
shear
stressinduc
hyperemia
helfield
et
al
report
sonopor
trigger
wide
rang
acoust
pressur
ultrasound
frequenc
unifi
physic
principl
requir
microbubbl
radial
expand
beyond
absolut
threshold
amount
confer
local
threshold
shear
stress
beyond
cell
membran
breach
sonopor
occur
desir
acoust
behavior
elicit
numer
stabl
inerti
cavit
regimen
find
extendedand
suggest
current
studyit
may
mani
differ
acoust
regimen
effect
drive
skelet
muscl
hyperemia
may
act
via
unifi
biophys
mechan
still
remain
incomplet
understood
anoth
interest
find
studi
absenc
direct
correl
magni
current
guidelin
risk
stratif
suggest
measur
natriuret
peptid
may
use
asymptomat
patient
determin
optim
time
avr
group
interest
role
angiotensinconvert
enzym
circul
biomark
cardiovascular
diseas
cvd
member
counterregulatori
axi
reninangiotensin
system
ra
main
role
degrad
prohypertroph
profibrot
peptid
angiotensin
ii
act
limit
advers
effect
angiotensin
ii
integr
membran
protein
express
heart
vascular
system
exist
membran
bound
solubl
form
latter
result
proteolyt
cleavag
ectodomain
proteinas
disintegrin
metalloproteinas
precis
relationship
tissu
circul
level
yet
understood
experiment
model
delet
loss
myocardium
associ
increas
level
tissu
angiotensin
ii
lead
cardiac
fibrosi
dysfunct
well
increas
level
circul
activ
healthi
individu
without
appar
cvd
circul
activ
low
circul
level
increas
predict
advers
event
presenc
cvd
includ
coronari
arteri
diseas
atrial
fibril
heart
failur
knowledg
studi
circul
myocardi
level
human
studi
common
valvular
heart
diseas
hypothes
plasma
activ
level
would
reflect
sever
andor
maladapt
myocardi
structur
chang
increment
prognost
use
predict
longterm
mortal
also
examin
relationship
plasma
activ
myocardi
gene
express
myocardi
fibrosi
subgroup
patient
underw
avr
studi
protocol
approv
human
research
ethic
committe
austin
health
helsinki
patient
gave
inform
written
consent
consecut
patient
age
older
year
attend
followup
cardiolog
valv
clinic
mild
moder
sever
recruit
june
may
part
prospect
studi
evalu
develop
progress
outcom
patient
anoth
valvular
lesion
greater
moder
sever
exclud
valvular
calcif
sever
classifi
use
echocardiographi
accord
current
guidelin
dobutamin
stress
echocardiographi
andor
valvular
calcium
score
multislic
comput
tomographi
use
determin
sever
discord
find
baselin
echocardiographi
abnorm
lv
eject
fraction
defin
use
sexspecif
cutoff
point
men
women
baselin
demograph
clinic
biochem
data
obtain
blood
collect
measur
patient
total
cohort
patient
underw
avr
patient
myocardi
tissu
collect
time
avr
blood
sampl
analysi
recruit
blood
collect
cold
lithium
heparin
tube
spun
rpm
c
min
plasma
store
c
measur
plasma
activ
perform
use
valid
sensit
quench
fluoresc
substratebas
assay
previous
describ
briefli
plasma
ml
dilut
lowion
strength
buffer
mmoll
trishcl
ph
ad
ml
anxsepharos
fastflow
resin
amersham
bioscienc
ge
healthcar
uppsala
sweden
remov
previous
character
endogen
inhibitor
activ
bind
wash
result
eluat
assay
catalyt
activ
duplic
park
illinoi
normal
valu
bnp
specif
age
sex
deriv
base
avail
data
abbott
laboratori
cohort
individu
without
diagnosi
heart
failur
patient
valu
maxim
limit
percentil
age
sex
consid
elev
bnp
patient
classifi
bnp
clinic
activ
previous
describ
myocardi
tissu
collect
patient
underw
avr
n
right
atrial
appendag
raa
tissu
obtain
site
cannul
cardiopulmonari
bypass
sampl
snap
frozen
isopentan
store
c
mrna
extract
remain
tissu
fix
paraformaldehyd
embed
paraffin
determin
interstiti
collagen
realtim
polymeras
chain
reaction
total
rna
isol
frozen
raa
use
rneasi
kit
method
qiagen
hilden
germani
cdna
synthes
revers
transcriptas
reaction
use
superscript
iii
thermofisch
scientif
victoria
australia
describ
previous
cardiac
tumor
necrosi
factora
convert
enzym
tace
also
known
gene
express
determin
use
predesign
human
taqman
assay
thermofisch
scientif
victoria
australia
fraction
myocardi
fibrosi
determin
previous
describ
briefli
raa
paraffin
section
thick
deparaffin
rehydr
stain
siriu
red
polysci
warrington
pennsylvania
satur
picric
acid
picrosiriu
red
h
differenti
hydrogen
chlorid
rapidli
dehydr
stain
quantifi
use
computer
imag
analysi
imag
research
ontario
canada
interstiti
collagen
volum
fraction
cvf
determin
measur
area
stain
tissu
within
given
field
exclud
epicardium
vessel
artefact
minor
scar
incomplet
tissu
field
field
analyz
per
sampl
blind
review
per
previou
classif
fibrosi
cvf
classifi
nonsever
fibrosi
cvf
sever
fibrosi
statist
analysi
statist
analysi
perform
use
stata
version
cox
proport
hazard
model
use
estim
adjust
hazard
ratio
hr
confid
interv
ci
allcaus
mortal
multivari
forward
stepwis
regress
perform
use
signific
variabl
univari
analysi
clinic
relev
identifi
independ
predictor
allcaus
mortal
plasma
enter
model
categor
dichotom
accord
optim
discriminatori
valu
determin
receiveroper
characterist
roc
curv
analysi
select
detect
primari
outcom
allcaus
mortal
combin
sensit
specif
closest
respect
supplement
figur
p
requir
variabl
enter
multivari
cox
model
p
method
idi
summar
new
model
abil
improv
integr
averag
sensit
without
sacrif
integr
averag
specif
gene
express
analysi
patient
divid
accord
median
plasma
activ
mrna
express
group
plasma
activ
less
equal
median
arbitrarili
standard
take
averag
result
group
gene
express
group
plasma
activ
median
express
rel
group
twotail
p
valu
consid
signific
cohort
consist
patient
mild
moder
sever
baselin
clinic
biochem
echocardiograph
characterist
present
tabl
men
mean
age
ae
year
high
preval
cardiovascular
risk
factor
andor
diseas
includ
hyperlipidemia
diabet
hypertens
ischem
heart
diseas
ihd
atrial
fibril
heart
failur
regard
baselin
medic
therapi
subject
ace
inhibitor
acei
angiotensin
receptor
blocker
arb
statin
betablock
abovemedian
plasma
activ
like
men
p
histori
ihd
higher
bodi
mass
index
p
signific
differ
baselin
pharmacolog
therapi
multivari
regress
analysi
male
sex
independ
clinic
predictor
higher
plasma
activ
p
proport
patient
bnp
clinic
activ
also
significantli
higher
abovemedian
plasma
activ
vs
p
figur
differ
hemoglobin
concentr
creatinin
level
group
p
plasma
activ
allcaus
mortal
median
durat
followup
year
iqr
year
period
patient
underw
avr
patient
die
higher
incid
allcaus
mortal
abovemedian
plasma
activ
compar
belowmedian
plasma
vs
logrank
p
roc
analysi
use
determin
plasma
valu
best
combin
sensit
specif
allcaus
mortal
roc
area
curv
ci
plasma
cutoff
valu
pmolmlmin
sensit
specif
detect
allcaus
mortal
supplement
figur
patient
plasma
activ
threshold
significantli
increas
likelihood
allcaus
mortal
compar
without
activ
hr
ci
p
figur
therefor
rocderiv
valu
use
subsequ
analysi
analyz
accord
sex
elev
plasma
activ
pmolmlmin
associ
higher
incid
allcaus
mortal
male
log
rank
test
p
femal
patient
logrank
test
p
respect
patient
bnp
activ
significantli
increas
likelihood
death
hr
ci
p
figur
allcaus
mortal
highest
combin
elev
plasma
activ
bnp
clinic
activ
hr
ci
p
figur
univari
predictor
mortal
includ
age
heart
failur
ihd
betablock
use
lv
mass
abnorm
lv
eject
fraction
sexspecif
bnp
clinic
activ
log
serum
creatinin
level
figur
lv
remodel
myocardi
fibrosi
ra
inhibit
posit
impact
regress
hypertrophi
improv
myocardi
physiolog
slow
rate
progress
valvular
stenosi
understand
ra
significantli
broaden
discoveri
gene
chang
simplist
vertic
view
ra
led
concept
counterregulatori
arm
oppos
effect
cardiovascular
biolog
key
find
studi
patient
increas
plasma
level
associ
myocardi
structur
abnorm
provid
ad
increment
prognost
inform
predict
longterm
mortal
convent
risk
marker
includ
bnp
activ
central
illustr
plasma
level
correl
extent
valvular
calcif
sever
median
level
cohort
pmolmlmin
similar
level
report
highrisk
cohort
coronari
arteri
diseas
median
pmolmlmin
higher
level
patient
atrial
fibril
young
healthi
volunt
mean
pmolmlmin
consist
previou
report
correl
activ
treatment
ace
inhibitor
male
sex
independ
predictor
increas
plasma
activ
result
add
grow
bodi
evid
plasma
activ
level
may
serv
marker
myocardi
abnorm
andor
advers
outcom
cardiovascular
diseas
includ
coronari
arteri
diseas
atrial
fibril
heart
failur
recent
report
elev
plasma
activ
independ
predictor
major
advers
cardiovascular
event
cardiovascular
mortal
heart
failur
myocardi
infarct
median
followup
year
patient
angiograph
proven
obstruct
coronari
arteri
diseas
plasma
level
also
reflect
cardiac
structur
alter
exampl
human
atrial
fibril
increas
plasma
activ
associ
advanc
left
atrial
structur
remodel
assess
electroanatom
map
patient
heart
failur
elev
circul
level
independ
predict
cardiovascular
event
death
cardiac
transplant
heart
failur
hospit
month
followup
posit
correl
imag
index
ventricular
remodel
dysfunct
similarli
follow
stsegment
elev
myocardi
infarct
circul
activ
increas
relat
infarct
size
correl
sever
lv
remodel
cardiac
magnet
reson
present
studi
extend
knowledg
regard
found
posit
correl
plasma
activ
lv
mass
although
relationship
bnp
brain
natriuret
peptid
ci
confid
interv
hr
hazard
ratio
ischem
heart
diseas
lvef
left
ventricular
eject
fraction
lvmi
left
ventricular
mass
index
abbrevi
tabl
rel
myocardi
mrna
patient
accord
median
plasma
activ
pmolmlmin
cohort
patient
gene
express
group
plasma
activ
less
equal
median
arbitrarili
standard
gene
express
group
plasma
activ
median
express
rel
group
data
express
mean
ae
sem
abbrevi
figur
patient
popul
like
influenc
presenc
hypertens
andor
antihypertens
therapi
furthermor
found
increas
plasma
activ
associ
increas
lv
diastol
volum
lv
eject
fraction
gl
data
suggest
potenti
role
measur
plasma
activ
level
marker
earli
myocardi
decompens
guidelin
risk
stratif
emphas
import
recogn
earli
myocardi
decompens
suggest
natriuret
peptid
level
may
use
asymptomat
patient
determin
optim
time
avr
class
iia
level
evid
c
plasma
bnp
activ
shown
independ
predict
longterm
mortal
prospect
studi
patient
least
moder
follow
year
recent
plasma
bnp
measur
enhanc
predict
allcaus
mortal
patient
lowflow
lowgradi
present
studi
patient
bnp
activ
elev
plasma
activ
increas
mortal
compar
without
elev
either
bnp
elev
biomark
plasma
measur
prognost
valu
captur
bnp
alon
combin
biomark
might
enhanc
clinic
decisionmak
importantli
patient
abovemedian
activ
normal
bnp
level
suggest
differ
pathophysiolog
mechan
andor
stimuli
releas
marker
bnp
acid
peptid
secret
heart
respons
myocardi
stretch
cardiac
volum
pressur
overload
wellestablish
role
risk
stratif
valvular
heart
diseas
highli
express
heart
undergo
cleavag
shed
releas
catalyt
activ
ectodomain
extracellular
milieu
process
involv
proteinas
also
known
tace
releas
heart
regul
variou
stimuli
includ
angiotensin
ii
loss
tissu
lead
unoppos
proinflammatori
profibrot
effect
angiotensin
ii
myocardium
experiment
mous
model
target
disrupt
loss
myocardi
led
increas
cardiac
angiotensin
ii
level
cardiac
hypertrophi
fibrosi
impair
cardiac
function
human
tissu
ace
upregul
downregul
stenot
aortic
valv
first
report
patient
describ
myocardi
gene
express
reduc
reduc
tissu
level
associ
elev
plasma
activ
highest
plasma
activ
sever
myocardi
fibrosi
import
predictor
death
studi
limit
strength
studi
includ
detail
cardiac
phenotyp
longterm
followup
well
assess
circul
myocardi
cardiac
fibrosi
import
limit
acknowledg
first
find
elev
plasma
activ
associ
abnorm
myocardi
function
increas
mortal
suggest
possibl
relationship
determin
causal
relationship
second
lv
first
extravalvular
cardiac
structur
affect
earliest
stage
patient
aortic
stenosi
elev
plasma
angiotensinconvert
enzym
activ
associ
reduc
myocardi
gene
express
myocardi
structur
abnorm
sever
myocardi
fibrosi
independ
predict
mortal
myocardi
damag
fibrosi
precis
relationship
tissu
circul
activ
yet
complet
understood
howev
seem
loss
tissu
associ
increas
circul
activ
furthermor
loss
tissu
associ
myocardi
fibrosi
associ
tissu
activ
myocardi
fibrosi
provid
caus
effect
relationship
previou
studi
shown
high
circul
level
predict
cardiovascular
event
patient
coronari
atherosclerosi
atrial
fibril
heart
failur
recent
myocardi
nativ
use
explor
chang
myocardi
blood
volum
vasodil
stress
suggest
nativ
potenti
detect
myocardi
ischemia
studi
protocol
figur
show
healthi
subject
protocol
imag
local
subject
underw
rest
cine
cmr
nativ
map
maxim
supin
bicycl
ergomet
exercis
follow
success
nativ
map
scan
assess
reproduc
healthi
subject
also
partook
second
exercis
follow
success
nativ
map
scan
session
peak
stress
target
base
achiev
heart
rate
least
age
age
year
figur
show
cad
patient
protocol
patient
cad
underw
rest
cine
cmr
nativ
map
maxim
exercis
follow
suc
tabl
figur
illustr
repres
nativ
map
imag
rest
postexercis
figur
show
mean
ae
sd
chang
whole
myocardium
statist
signific
differ
baselin
time
point
obtain
use
linear
mixedeffect
model
estim
fix
effect
nativ
elev
healthi
subject
immedi
exercis
tend
decreas
second
scan
exercis
complet
return
baselin
third
scan
min
exercis
complet
differ
reactiv
basal
midventricular
apic
slice
ae
vs
ae
vs
ae
similarli
statist
differ
intersegment
reactiv
valu
p
trend
also
observ
second
exercis
indic
could
surrog
marker
detect
myocardi
blood
flow
contrast
gradual
increas
pronounc
second
scan
figur
show
relationship
nativ
reactiv
mrpp
exercis
figur
show
analysi
use
linear
mixedeffect
model
r
e
c
n
f
e
r
e
x
c
n
f
e
r
n
e
x
n
c
n
n
c
n
r
c
n
healthi
subject
septal
nativ
significantli
elev
immedi
first
approxim
exercis
complet
second
exercis
approxim
exercis
complet
b
increas
significantli
pronounc
second
scan
previou
inferior
myocardi
infarct
inferior
fix
defect
spect
rest
andor
stress
nativ
map
show
higher
nativ
time
basal
inferior
wall
reactiv
map
demonstr
sever
reduc
reactiv
right
coronari
arteri
rca
territori
lad
left
anterior
descend
lcx
left
circumflex
abbrevi
figur
exercisestress
map
function
cad
detect
abnorm
myocardi
blood
flow
exercis
demonstr
chang
nativ
could
surrog
marker
detect
myocardi
blood
flow
exercis
reactiv
associ
sever
myocardi
perfus
abnorm
spectmpi
importantli
combin
assess
rest
nativ
reactiv
potenti
differenti
ischem
myocardium
infarct
myocardium
result
studi
consist
recent
report
liu
et
al
show
preandor
postn
increas
myocardi
blood
flow
vasodil
adenosin
stress
predict
myocardi
ischemia
patient
cad
exercis
stress
provid
addit
inform
unobtain
pharmacolog
stress
hemodynam
respons
symptom
exercis
exercis
stress
prefer
cardiac
stress
test
patient
unwil
unabl
toler
pharmacolog
stress
despit
import
exercis
stress
cardiac
test
clinic
use
exercisestress
cmr
limit
difficult
imag
acquisit
high
heart
rate
rapid
andor
deep
breath
introduct
freebreath
nativ
map
enabl
measur
whole
heart
within
pharmacolog
exercis
stress
could
lead
differ
cutoff
reactiv
valu
detect
flowlimit
coronari
arteri
stenosi
current
spectmpi
commonli
use
stress
test
well
valid
neg
result
provid
reassur
prognost
inform
found
segment
myocardi
perfus
abnorm
spectmpi
lower
reactiv
importantli
integr
nativ
rest
allow
differenti
revers
fix
perfus
defect
addit
pilot
studi
exercis
stress
andor
rest
map
seem
similar
spectmpi
abil
detect
signific
cad
exercis
stress
andor
rest
map
could
overcom
limit
soft
tissu
attenu
low
spatial
resolut
spectmpi
multicent
perfus
cmr
studi
show
sensit
specif
auc
detect
signific
cad
coronari
xray
angiographi
similarli
larg
cemarc
cmr
studi
demonstr
auc
comprehens
cmr
left
ventricular
function
myocardi
perfus
late
gadolinium
enhanc
coronari
arteri
imag
auc
valu
slightli
higher
exercis
stress
andor
rest
nativ
map
present
studi
demonstr
exercis
stress
andor
rest
nativ
map
could
effect
altern
radionuclid
mpi
detect
flowlimit
coronari
stenosi
without
gbca
ioniz
radiat
consid
patholog
prognost
aspect
myocardi
tissu
character
myocardi
scar
andor
diffus
fibrosi
edema
rest
nativ
map
exercis
stress
andor
rest
map
might
potenti
improv
patient
outcom
substanti
differ
regress
analysi
reactiv
relat
mrpp
normal
myocardium
healthi
young
subject
remot
myocardium
patient
cad
differ
might
partli
explain
impair
microvascular
dilat
exercis
remot
myocardium
mrpp
index
best
correl
myocardi
oxygen
consumpt
altern
reduct
oxygen
suppli
might
decreas
contractil
patient
cad
turn
reduc
oxygen
cost
exercis
toler
differ
reactiv
versu
mrpp
relationship
due
differ
blood
catecholamin
level
factor
would
result
chang
opposit
direct
myocardi
theoret
sensit
chang
myocardi
water
content
secondari
increas
myocardi
blood
flow
stress
femal
angina
effort
singlevessel
diseas
reactiv
map
demonstr
lower
reactiv
midanterosept
apex
wall
midlad
reveal
sever
stenosi
coronari
angiographi
arrow
stress
spectmpi
show
moder
sever
perfus
defect
lad
territori
confirm
flowlimit
stenosi
reactiv
lad
territori
sever
reduc
case
b
male
angina
effort
ventricular
arrhythmia
singlevessel
diseas
coronari
angiographi
reveal
singlevessel
diseas
rca
total
occlus
arrow
rich
collater
left
coronari
arteri
stress
spectmpi
show
mild
moder
perfus
defect
suggest
flowlimit
lesion
reactiv
map
demonstr
lower
reactiv
correspond
myocardi
segment
reactiv
rca
territori
moder
decreas
figur
howev
current
map
techniqu
might
necessari
sensit
need
detect
chang
myocardi
associ
chang
blood
flow
stress
serial
chang
time
exercis
might
also
explain
map
detect
subclin
myocardi
edema
intens
exercis
observ
approxim
variat
myocardi
among
healthi
volunt
anoth
potenti
sourc
variat
could
attribut
imag
physiolog
confound
myocardi
map
includ
sensit
field
inhomogen
might
advantag
relat
andor
blood
oxygen
sensit
magnet
transfer
effect
studi
warrant
assess
rigor
studi
limit
first
present
studi
singlecent
small
proofofconcept
studi
small
sampl
size
neither
myocardi
blood
flow
perfus
directli
measur
howev
known
mrpp
well
correl
myocardi
blood
flow
myocardi
oxygen
consumpt
exercis
would
ideal
healthi
subject
partak
second
exercis
follow
nativ
map
scan
separ
day
assess
reproduc
reactiv
assess
middl
slice
cover
left
ventricl
report
degre
reactiv
heterogen
healthi
control
subject
howev
reactiv
might
homogen
across
left
ventricl
middl
slice
true
basal
midventricular
apic
slice
analyz
exercis
stress
andor
rest
nativ
map
valid
perfus
cmr
late
gadolinium
enhanc
cmr
reliabl
measur
nativ
thinwal
area
might
challeng
howev
present
studi
demonstr
might
applic
infarct
myocardium
character
thin
myocardi
wall
studi
small
assess
diagnost
accuraci
propos
exercis
stress
andor
rest
map
protocol
anatom
cad
use
gbca
pharmacolog
stressor
agent
undesir
prohibit
suboptim
specif
patient
group
gbca
contraind
patient
sever
renal
dysfunct
ongo
concern
field
regard
whether
detect
gadolinium
deposit
brain
clinic
relev
attempt
made
develop
method
elimin
gbca
cmr
approach
assess
myocardi
perfus
ischemia
test
dobutamin
stress
cmr
requir
gbca
evalu
contractil
reserv
induc
wall
motion
abnorm
shown
diagnost
accuraci
prognost
strength
howev
although
dobutamin
stress
cmr
establish
justifi
role
cardiac
imag
diagnost
arsen
seen
widespread
clinic
adopt
use
perfus
assess
use
vasodil
stress
nativ
map
vasodil
stress
emerg
perfus
assess
approach
shown
initi
promis
tool
assess
myocardi
ischemia
howev
like
blood
oxygen
leveldepend
arteri
spin
label
approach
nativ
map
challeng
includ
imag
artifact
imag
contrast
normal
ischem
myocardium
small
magnitud
differ
rel
high
variabl
noncontrast
techniqu
yet
show
data
form
convinc
imag
low
nois
visual
conspicu
differ
normal
ischem
myocardium
routin
clinic
patient
regard
limit
pharmacolog
stressor
adenosin
requir
continu
intraven
infus
contraind
select
condit
particular
sever
asthma
although
regadenoson
offer
eas
bolu
inject
contraind
asthma
match
adenosin
abil
provid
ad
benefit
abl
detect
inadequ
stress
use
splenic
switchoff
sign
furthermor
adenosin
regadenoson
hamper
fact
caffein
power
antagonist
vasodilatori
effect
complic
data
show
patient
undergo
vasodil
stress
residu
level
caffein
blood
like
due
delay
caffein
metabol
rather
noncompli
regard
avoid
caffein
consumpt
physiolog
stress
evalu
ischem
heart
diseas
use
exercis
sever
advantag
approach
use
pharmacolog
stress
impetu
stress
test
often
symptom
patient
experi
exert
myocardi
ischemia
caus
symptom
would
preferenti
assess
similar
circumst
psycholog
benefit
give
patient
confid
symptom
assess
circumst
similar
daili
live
exercis
stress
also
ad
benefit
provid
import
prognost
inform
regard
durat
exercis
well
heart
rate
blood
pressur
dynam
exercis
imag
cmr
requir
patient
lie
insid
bore
scanner
time
imag
thu
exercis
must
either
perform
insid
scanner
exampl
use
contrastenhanc
firstpass
perfus
supin
bicycl
outsid
scanner
approach
perform
exercis
treadmil
immedi
transit
scanner
perform
cmr
perfus
use
gbca
shown
excel
multicent
diagnost
perform
problem
earli
develop
field
show
abil
detect
metabol
chang
associ
myocardi
ischemia
use
cmr
spectroscopi
handgrip
exercis
perform
insid
scanner
arguabl
first
exampl
gad
drug
cmr
test
myocardi
ischemia
issu
ijacc
nakamori
et
al
add
bodi
literatur
cardiac
imag
techniqu
gad
drug
cmr
approach
evalu
myocardi
ischemia
combin
inscann
supin
bicycl
exercis
stress
nativ
map
pilot
studi
patient
show
reactiv
exercis
stress
could
detect
physiolog
signal
relat
exerciseinduc
myocardi
ischemia
associ
sever
myocardi
perfus
defect
singlephoton
emiss
comput
tomographi
first
time
investig
present
rest
stress
nativ
map
imag
use
color
scale
possibl
visual
evalu
magnitud
variabl
differ
remot
ischem
myocardium
map
manual
defin
region
interest
measur
illustr
although
novel
work
applaud
show
approach
detect
signal
number
hurdl
remain
techniqu
provid
convinc
imag
robust
clinic
adopt
taken
togeth
innov
race
quadrimod
tug
war
among
cardiac
imag
modal
vy
posit
test
choic
evalu
stressinduc
myocardi
ischemia
born
new
kid
block
hinchliff
rule
tell
us
research
paper
titl
form
yesno
question
answer
question
inde
propos
techniqu
free
problem
ongo
research
field
continu
innov
improv
mous
trap
inform
continu
evolut
field
cardiac
imag
c
ardiac
magnet
reson
cmr
enabl
full
coverag
heart
use
high
spatial
tempor
resolut
without
constraint
limit
acquisit
window
use
ioniz
radiat
echocardiographi
computedtomographi
cine
cmr
becom
gold
standard
noninvas
quantif
cardiac
volum
eject
fraction
ef
howev
cine
cmr
imag
hold
significantli
detail
inform
allow
quantif
advanc
marker
cardiac
function
ventricular
shape
eject
fill
rate
myocardi
wall
motion
myocardi
strain
paramet
shown
valuabl
biomark
earlier
detect
monitor
diseas
howev
obtain
time
step
step
step
step
short
axi
eject
paramet
well
circ
long
rad
stratifi
sex
shown
tabl
supplement
tabl
show
regress
analysi
chang
cardiac
function
men
women
age
studi
present
valid
pipelin
autom
analysi
ventricular
function
cine
cmr
pipelin
sole
dl
imag
analysi
algorithm
framework
includ
extens
qc
step
allow
fulli
automat
process
larg
number
cmr
dataset
without
direct
clinician
oversight
show
use
propos
techniqu
abl
obtain
detail
descript
cardiac
function
healthi
individu
author
best
knowledg
first
comprehens
framework
autom
cine
cmr
analysi
approach
clinic
standard
qc
autom
qc
qc
essenti
develop
dl
algorithm
autom
process
clinic
data
far
mostli
overlook
framework
implement
qc
separ
step
preanalysi
control
imag
qualiti
postanalysi
control
qualiti
output
paramet
tabl
sensit
error
detect
sensit
specif
balanc
accuraci
bacc
pipelin
detect
inaccur
unusu
output
versu
correct
output
respect
manual
assess
shown
ruijsink
et
al
abbrevi
tabl
within
field
machin
learn
lowhang
fruit
often
thought
autom
task
easi
tediou
without
doubt
quantit
analysi
cmr
imag
tediou
easi
answer
question
lie
natur
imag
signaltonois
spatial
resolut
high
motion
artifact
absent
heart
physiolog
normal
quantit
analysi
typic
easi
difficulti
rise
exponenti
howev
imag
qualiti
poor
imag
acquir
patient
aspect
cardiac
structur
function
differ
markedli
normal
volunt
train
model
use
automat
analyz
second
group
patient
result
autom
analys
classifi
right
wrongunusu
human
cmr
expert
rightwrong
classif
use
defin
sensit
specif
report
tabl
ruijsink
et
al
high
sensit
mean
autom
qc
correctli
reject
solut
human
cmr
expert
judg
wrong
typic
tabl
ruijsink
et
al
high
specif
mean
qc
correctli
accept
solut
human
cmr
expert
judg
right
typic
lower
rang
tabl
ruijsink
et
al
train
model
use
determin
normal
rang
cardiac
function
paramet
healthi
subject
uk
biobank
dataset
tabl
ruijsink
et
al
strain
mean
roughli
onequart
autom
attempt
fail
provid
meaning
solut
even
healthi
subject
moreov
imag
use
studi
acquir
singl
magnet
field
strength
appear
come
primarili
singl
medic
center
suggest
train
model
may
perform
well
divers
clinic
environ
point
author
howev
principl
train
method
present
could
repeat
use
larger
divers
set
train
imag
greatli
facilit
author
public
open
sourc
softwar
quantit
analysi
cmr
imag
tediou
time
consum
machin
learn
work
well
task
easi
tediou
rapid
progress
made
remov
tediou
natur
quantit
cmr
imag
analysi
pitfal
like
expos
task
nt
easi
realist
expect
full
autom
achiev
next
decad
use
routin
clinic
set
sick
patient
imag
mri
scanner
differ
field
strength
manufactur
puls
sequenc
protocol
perhap
realist
goal
machin
learn
cmr
would
fast
semiautomat
physician
time
report
paper
myocardi
fibrosi
document
accord
histopatholog
studi
patient
associ
increas
morbid
mortal
cardiac
magnet
reson
cmr
imag
offer
noninvas
accur
reproduc
assess
lv
architectur
function
cmr
imag
detect
presenc
replac
myocardi
fibrosi
use
late
gadolinium
enhanc
lge
diffus
reactiv
myocardi
fibrosi
use
extracellular
volum
ecv
fraction
calcul
map
lge
ecv
correl
strongli
collagen
content
measur
histolog
investig
suggest
surrog
marker
myocardi
fibrosi
recent
studi
report
associ
lge
ecv
wors
outcom
patient
sever
factor
particular
age
sex
may
also
effect
expans
diffus
myocardi
fibrosi
key
marker
lv
decompens
object
current
studi
therefor
assess
determin
diffus
ecv
focal
lge
myocardi
fibrosi
patient
particular
assess
effect
sex
type
fibrosi
institut
edinburgh
heart
centr
inclus
exclus
criteria
describ
previous
patient
enrol
prospect
studi
underw
echocardiographi
cmr
examin
includ
analysi
supplement
figur
studi
approv
local
ethic
committe
patient
provid
written
inform
consent
consid
statist
signific
figur
preval
lv
hypertrophi
differ
sex
vs
p
howev
trend
toward
lv
concentr
remodel
concentr
hypertrophi
men
compar
women
systol
function
measur
accord
lv
eject
fraction
differ
sex
p
lge
studi
popul
lge
present
patient
noninfarct
lge
present
patient
tabl
trend
toward
higher
proport
patient
detect
lge
figur
howev
signific
differ
sex
accord
tertil
lv
mass
index
p
figur
univari
linear
regress
analysi
whole
studi
popul
show
v
peak
lv
mass
index
associ
higher
lge
p
wherea
trend
toward
associ
coronari
arteri
diseas
lge
p
figur
p
betweengroup
figur
howev
slope
correl
line
v
peak
ecv
fraction
steeper
p
ancova
men
women
suggest
pronounc
impact
asrel
pressur
overload
lv
fibrosi
men
women
figur
also
effect
sex
relationship
lv
mass
index
ecv
p
ancova
tabl
analys
ecv
fraction
accord
sex
within
center
yield
similar
result
supplement
figur
fraction
whole
cohort
age
p
femal
sex
p
hematocrit
p
significantli
associ
ecv
fraction
fill
pressur
ee
ratio
may
relat
reduc
lv
complianc
advanc
lv
diastol
dysfunct
women
degre
lv
hypertrophyremodel
studi
found
associ
sever
lv
mass
index
ecv
men
women
figur
supplement
figur
moreov
women
higher
ecv
men
regardless
degre
sever
altogeth
result
suggest
men
expans
ecv
mainli
driven
sever
extent
lv
hypertrophi
wherea
women
lv
respons
asrel
pressur
overload
term
remodel
hypertrophi
fibrosi
heterogen
multifactori
suscept
fibrosi
mostli
attribut
sex
hormon
estrogen
could
exert
cardioprotect
effect
femal
heart
howev
patient
year
age
effect
sex
hormon
profibrot
process
postmenopaus
women
remain
unknown
convers
chronic
activ
reninangiotensinaldosteron
system
believ
play
key
role
cardiac
remodel
process
well
profibrot
process
evid
suggest
process
may
predominantli
affect
femal
heart
studi
need
determin
underli
mechan
sex
differ
magnitud
myocardi
fibrosi
patient
best
knowledg
current
studi
first
perform
separ
analys
explanatori
variabl
increas
diffus
replac
fibrosi
women
men
women
variabl
associ
higher
ecv
fraction
interestingli
older
age
presenc
coronari
arteri
diseas
lv
mass
index
associ
higher
lge
latter
find
could
reflect
presenc
impair
coronari
microcircul
relat
lv
hypertroph
respons
increas
lv
transmur
pressur
associ
studi
report
among
patient
coronari
microcircul
frequent
impair
women
men
older
age
higher
lv
mass
index
associ
higher
ecv
fraction
lv
mass
index
strongest
variabl
tastet
et
al
associ
higher
lge
therefor
men
lv
hypertroph
respons
due
chronic
pressur
overload
seem
main
factor
advers
lv
remodel
subsequ
fibrosi
supplement
figur
outcom
consist
previou
studi
report
maladapt
lv
remodel
associ
activ
profibrot
marker
predominantli
men
associ
older
age
higher
ecv
fraction
men
previous
report
find
also
support
histolog
evid
suggest
age
process
associ
myocyt
cell
loss
affect
myocardium
men
women
ecv
fraction
specif
fibrosi
thu
possibl
larger
ecv
fraction
women
could
relat
mani
factor
includ
intravascular
compart
rather
interstiti
expans
due
diffus
myocardi
fibrosi
howev
multipl
histolog
studi
sex
differ
lv
respons
investig
sever
decad
convent
find
use
echocardiographi
women
exagger
respons
pressur
overload
mark
concentr
lv
hypertrophi
supernorm
lv
eject
fraction
men
higher
lv
mass
index
lower
normal
lv
eject
fraction
result
lv
hypertrophi
induc
high
afterload
myocardi
ischemia
well
myocyt
apoptosi
fibrosi
occur
howev
find
tastet
et
al
consist
previou
report
summar
tabl
figur
previou
studi
show
similar
larger
late
gadolinium
enhanc
ecv
men
probabl
relat
differ
studi
popul
studi
evalu
symptomat
patient
sever
wherea
current
report
evalu
patient
mild
sever
fact
inclus
less
sever
studi
led
find
higher
ecv
fraction
women
indic
signific
background
myocardi
fibrosi
relat
age
femal
sex
relat
concentr
lv
hypertrophi
frequent
women
echocardiographi
use
men
cardiac
magnet
reson
imag
use
echocardiographi
data
patient
sever
show
concentr
hypertrophi
common
women
men
vs
sever
figur
larger
smaller
larger
lv
hypertrophi
concentr
lvh
lv
remodel
pattern
similar
men
dilat
lv
lv
massvolum
smaller
normal
geometri
concentr
remodel
common
lv
massvolum
similar
sex
concentr
lvh
eccentr
lvh
higher
differ
sex
higher
similar
sex
much
higher
differ
sex
strain
lv
contractil
lv
contractil
commonli
declin
longitudin
strain
similar
sex
ecv
larger
smaller
smaller
larger
lge
larger
smaller
similar
sex
outcom
women
concentr
lvh
wors
prognosi
sex
affect
earli
mortal
rate
men
women
equal
symptomat
symptom
common
symptomat
statu
similar
sex
symptom
onset
much
higher
cmr
cardiac
magnet
reson
ecv
extracellular
volum
fraction
lge
late
gadolinium
enhanc
lv
left
ventricl
lvef
left
ventricular
eject
fraction
lvh
left
ventricular
hypertrophi
editori
comment
classif
cardiac
magnet
reson
imag
despit
discord
result
clear
sex
differ
lv
reaction
exist
howev
clear
mechan
drive
differ
sex
differ
probabl
result
interact
molecular
pathway
direct
sex
chromosom
hormon
although
differ
chang
sex
steroid
across
life
cours
may
contribut
differ
cellular
remodel
contribut
sex
chromosom
investig
systemat
preclin
model
ventricular
diseas
although
data
continu
accumul
identifi
sex
differ
phenotyp
characterist
question
follow
data
could
nonculprit
lesion
present
approxim
patient
stemi
left
unattend
carri
poor
prognosi
patient
cmr
special
interest
allow
simultan
assess
left
ventricular
function
infarct
size
perfus
cmr
thu
provid
valuabl
prognost
inform
also
identifi
patient
ischemia
nonculprit
vascular
territori
may
benefit
revascular
aim
present
studi
determin
agreement
cmr
invas
mea
subject
physiolog
interrog
also
regard
hemodynam
obstruct
subset
vessel
thermodilut
deriv
coronari
flow
reserv
cfr
thermo
index
microcirculatori
resist
imr
determin
describ
previous
tabl
time
followup
cmr
ica
time
ppci
cmr
day
time
ppci
followup
ica
day
tabl
splenic
switchoff
present
patient
randomli
assign
revascular
optim
medic
therapi
revascular
associ
reduct
cardiac
event
everaar
et
al
wong
report
relationship
relev
content
paper
disclos
infus
rate
ml
follow
ml
salin
solut
scan
window
base
hr
bodi
mass
indexadapt
scan
protocol
use
previous
describ
given
supplement
figur
vasodilat
induc
intraven
adenosin
inject
mgkgmin
min
impair
signalimagetonois
ratio
case
tabl
segmentbas
analysi
tabl
territoryand
patientbas
analys
among
stent
classifi
evalu
coronari
cta
correctli
territori
patientbas
analys
supplement
tabl
stentbas
analysi
abbrevi
tabl
abbrevi
tabl
andreini
et
al
andreini
et
al
background
next
lesion
sever
plaqu
vulner
assess
use
coronari
ct
angiographi
affect
fraction
flow
reserv
ffr
associ
immin
acut
coronari
syndrom
instantan
wavefre
ratio
ifr
recent
emerg
altern
ffr
interrog
coronari
lesion
ischemia
howev
unknown
whether
vasodilatorfre
assess
ifr
associ
plaqu
stabil
similarli
ffr
ctderiv
plaqu
characterist
relat
invas
pressur
measur
result
atherosclerot
plaqu
present
coronari
arteri
pervessel
basi
lumin
stenosi
sever
significantli
associ
impair
ffr
ifr
pdpa
ifra
multivari
analysi
reveal
ffr
ifr
independ
relat
stenosi
p
p
respect
plaqu
volum
p
p
respect
addit
pr
sc
also
independ
predictor
impair
ffr
p
p
respect
advers
plaqu
characterist
independ
relat
vasodilatorfre
ifr
anatom
point
view
grow
bodi
literatur
recogn
major
share
acut
coronari
event
origin
nonobstruct
socal
vulner
plaqu
prone
ruptur
atherosclerot
plaqu
morpholog
assess
noninvas
use
coronari
comput
tomographi
ct
angiographi
describ
strong
predictor
advers
event
recent
highrisk
plaqu
link
hyperem
myocardi
blood
flow
ffr
independ
lumin
stenosi
sever
hypothet
might
part
explain
relationship
low
ffr
risk
cardiac
event
beyond
angiograph
stenosi
signific
wherea
ffr
measur
requir
hyperem
state
instantan
wavefre
ratio
ifr
recent
emerg
novel
invas
physiolog
measur
obviat
need
hyperemia
notwithstand
seemingli
compar
relat
flow
well
shortterm
outcom
yet
studi
describ
associ
ifr
highrisk
plaqu
morpholog
lack
could
provid
insight
regard
current
debat
differ
equal
ffr
ifr
accordingli
aim
present
studi
investig
differ
ffr
nonhyperem
ifr
relationship
ctderiv
highrisk
plaqu
featur
pet
pet
scan
protocol
describ
detail
previous
summari
dynam
pet
softwar
among
variou
highrisk
plaqu
featur
deriv
ct
lap
pr
frequent
found
next
less
preval
sc
nr
quantit
associ
plaqu
calciumchannel
blocker
longact
nitrat
typic
angina
atyp
angina
nonspecif
chest
discomfort
valu
mean
ae
sd
n
ace
angiotensinconvert
enzym
arb
angiotensin
ii
receptor
blocker
cad
coronari
arteri
diseas
valu
n
mean
ae
sd
cac
coronari
arteri
calcium
ct
comput
tomographi
ffr
fraction
flow
reserv
ifr
instantan
wavefre
ratio
ifra
instantan
wavefre
ratio
adenosin
pdpa
distal
coronari
arteri
pressureaort
pressur
tabl
univari
analysi
obstruct
stenosi
coronari
arteri
calcium
score
plaqu
volum
nearli
highrisk
plaqu
featur
invers
relat
detriment
flow
paramet
hyperem
nonhyperem
tabl
although
coeffici
valu
could
normal
systemat
numer
trend
shown
non
accord
establish
cutoff
valu
dichotom
ffr
ifr
show
discord
result
case
discord
often
occur
lad
lesser
extent
rca
lcx
total
vessel
show
normal
ffr
abnorm
ifr
measur
wherea
opposit
result
found
similar
number
vessel
figur
show
mean
stenosi
sever
vessel
concord
neg
ffr
ifr
significantli
lower
stenosi
either
one
ffr
ifr
posit
coronari
arteri
dissimilar
ffrifr
test
result
howev
mean
stenosi
sever
differ
accordingli
figur
tabl
abbrevi
tabl
present
subanalysi
prospect
pacif
trial
aim
explor
relationship
ctderiv
highrisk
atherosclerot
plaqu
morpholog
ffr
comparison
vasodilatorfre
ifr
multivari
model
includ
lumin
stenosi
sever
plaqu
volum
advers
plaqu
featur
show
pr
sc
next
stenosi
sever
independ
predictor
abnorm
ffr
ifra
rest
indic
pdpa
ifr
furthermor
vessel
abnorm
ffr
despit
preserv
ifr
show
significantli
highrisk
plaqu
featur
opposit
group
abnorm
ifr
physiolog
measur
predict
outcom
current
studi
may
provid
new
insight
previous
report
fulli
elucid
find
data
ifr
instantan
wavefre
ratio
ifra
pressur
ratio
adenosin
within
wavefre
period
pdpa
distal
coronari
arteri
pressureaort
pressur
roc
receiveroper
characterist
figur
indic
shown
increment
predict
valu
also
plaqu
assess
remain
variabl
extent
interobserv
reproduc
previous
report
final
although
current
find
provid
new
insight
relationship
physiolog
paramet
plaqu
morpholog
clinic
event
highli
complex
remain
yet
fulli
understood
present
subanalysi
prospect
pa
studi
also
strongli
suggest
activ
progress
atheroma
associ
wors
outcom
stabl
diseas
treatment
halt
progress
atherosclerosi
eg
lipidlow
therapi
medic
alter
probabl
vascular
thrombosi
respons
plaqu
disrupt
eg
antiplatelet
therapi
known
reduc
risk
myocardi
infarct
death
patient
coronari
heart
diseas
convers
treat
individu
plaqu
coronari
stent
even
though
target
lesion
exhibit
call
vulner
characterist
shown
reduc
risk
myocardi
infarct
death
mani
random
control
trial
patient
stabl
coronari
heart
diseas
surpris
consid
individu
plaqu
associ
low
risk
catastroph
event
valu
mean
ae
sd
n
cad
coronari
arteri
diseas
ccta
coronari
comput
tomographi
angiographi
ctffr
coronari
comput
tomographi
angiographyderiv
fraction
flow
reserv
ffr
fraction
flow
reserv
abbrevi
figur
tesch
et
al
baselin
characterist
studi
cohort
present
tabl
figur
tabl
show
superior
diagnost
perform
ccta
figur
repres
exampl
ccta
ctffr
ica
ffr
shown
figur
key
find
shown
central
addit
case
exampl
provid
supplement
appendix
imag
time
min
scanner
oneday
reststress
stressrest
stressonli
stressrest
protocol
perform
accord
sitespecif
protocol
patient
underw
symptomlimit
standard
exercis
treadmil
test
pharmacolog
stress
rate
event
calcul
use
kaplanmei
analysi
stratif
visual
assess
tpd
overal
popul
otaki
et
al
subgroup
suspect
cad
logrank
test
use
assess
differ
event
risk
worsen
visual
perfus
quantit
perfus
assess
among
classifi
group
integ
valu
consid
tpd
analysi
stress
tpd
categori
previous
establish
threshold
diagnost
abnorm
sss
consid
equival
tpd
use
abnorm
threshold
clinic
read
visual
score
sss
sss
consid
approxim
equival
tpd
tabl
overal
popul
patient
characterist
overal
popul
without
mace
shown
tabl
compar
group
patient
without
mace
mace
group
older
consist
male
pharmacolog
stress
test
commonli
use
patient
mace
incid
ischem
ecg
chang
higher
patient
mace
tabl
among
patient
suspect
cad
supplement
tabl
similarli
unadjust
adjust
cox
proport
analys
higher
rate
mace
associ
increas
stress
tpd
overal
popul
tabl
among
patient
suspect
cad
supplement
tabl
stress
tpd
sss
sum
stress
score
abbrevi
figur
otaki
et
al
present
studi
patient
visual
score
normal
mace
rate
also
increas
progress
increas
interv
stress
tpd
cardiologist
real
practic
observ
signific
mace
risk
increas
probabl
normal
equivoc
categori
compar
risk
normal
categori
howev
probabl
normal
often
avoid
equivoc
reserv
visual
analysi
author
appli
commonli
accept
categori
normal
probabl
normal
equivoc
abnorm
subset
patient
imag
score
onsit
use
model
imag
also
categor
use
stress
imag
sum
stress
score
sss
normal
despit
much
progress
prospect
identif
rupturepron
plaqu
would
crucial
stratifi
risk
improv
patient
manag
remain
elus
current
oct
ofdi
modal
reli
subject
interpret
fall
short
provid
object
quantit
assess
plaqu
morpholog
composit
recent
introduc
intravascular
polarimetri
use
polarizationsensit
ps
ofdi
combin
standard
intravascular
ofdi
cathet
intravascular
polarimetri
complement
highresolut
imag
subsurfac
microstructur
known
oct
ofdi
polarimetr
measur
tissu
birefring
depolar
tissu
fibrillar
architectur
interstiti
collagen
layer
array
arteri
smooth
muscl
cell
exhibit
birefring
serv
assess
collagen
smooth
muscl
cell
content
depolar
correspond
random
detect
polar
state
tabl
coregistr
convent
ofdi
polarimetr
signal
intrins
addit
lumen
segment
intern
elast
lamina
whenev
visibl
use
birefring
map
leverag
improv
visibl
media
birefring
map
area
intern
elast
lamina
segment
unattain
typic
lipidrich
area
advanc
lesion
automat
outer
border
correspond
tissu
depth
mm
within
fibrou
cap
shown
correl
macrophag
infiltr
nsd
comput
first
evalu
sd
linearscal
backscatt
intens
data
within
ellipt
figur
figur
calcif
locat
fibrou
tissu
exhibit
lower
birefring
depolar
lipidrich
lesion
p
shown
supplement
figur
thrombu
white
thrombu
present
low
birefring
depolar
supplement
figur
culprit
lesion
lipid
arc
minimum
fibrou
cap
thick
differ
statist
signific
ac
andor
pr
sap
group
shown
tabl
compar
polarimetr
signal
fibrou
cap
culprit
lesion
found
lower
birefring
ac
andor
pr
group
patient
sap
p
compar
depolar
p
figur
tabl
show
gener
estim
equat
relationship
polar
properti
clinic
optic
frequenc
domain
imag
paramet
determin
unadjust
gener
linear
model
use
gener
estim
equat
take
consider
intrasubject
correl
among
multipl
crosssect
imag
individu
patient
beta
valu
ci
birefring
given
unit
abbrevi
tabl
less
advanc
stage
atherogenesi
birefring
depolar
increas
along
prolifer
thick
collagen
smooth
muscl
cell
lipid
content
atherogenesi
progress
birefring
plaqu
declin
hand
reduct
interstiti
collagen
develop
lipidnecrot
core
turn
lead
signific
increas
depolar
correspond
transit
patholog
intim
thicken
fibrou
plaqu
fp
fibrofatti
plaqu
ff
fibroatheroma
progress
destabil
ac
acut
coronari
syndrom
fc
fibrocalcifi
plaqu
pr
plaqu
ruptur
otsuka
et
al
histopatholog
studi
show
ruptur
fibrou
cap
lack
layer
smooth
muscl
cell
featur
differ
collagen
phenotyp
intact
cap
offer
explan
low
birefring
observ
fibrou
cap
patient
ac
andor
pr
addit
cap
birefring
minimum
fibrou
cap
thick
lipid
arc
angl
also
featur
statist
signific
differ
patient
group
yet
fibrou
cap
thick
alon
insuffici
identifi
cap
prone
ruptur
polar
metric
avail
intravascular
polarimetri
complement
structur
featur
may
advanc
understand
pathogenesi
ac
without
fibrou
cap
ruptur
second
plaqu
classif
correspond
well
current
understand
plaqu
subtyp
ofdi
could
readili
perform
convent
ofdi
signal
yet
convent
ofdi
limit
abil
classifi
lesion
type
especi
advanc
lesion
although
lipidrich
plaqu
offer
prognost
implic
predict
perspect
plaqu
composit
assess
patient
stabl
unstabl
cad
associ
develop
futur
clinic
event
optic
coher
tomographi
oct
highresolut
intravascular
imag
techniqu
assay
coronari
wall
structur
histopatholog
scale
mm
use
detect
highrisk
plaqu
howev
predict
abil
oct
intracoronari
imag
modal
remain
modest
quest
new
prognost
develop
intracoronari
imag
arena
ongo
finit
element
model
fem
wide
accept
comput
tool
biomechan
profil
coronari
plaqu
fem
plaqu
contour
determin
use
ideal
model
histolog
cross
section
imag
tool
virtual
histolog
ivu
comput
tomographi
ct
contour
discret
mesh
tensil
stress
mathemat
deriv
respons
physiolog
pressur
inform
materi
properti
constitu
tissu
sever
fem
studi
underscor
import
local
maximum
peak
tensil
stress
fibrou
cap
indic
peak
stress
profoundli
relat
propens
plaqu
ruptur
ensu
risk
acut
coronari
event
variou
morpholog
factor
includ
fibrou
cap
thick
nc
size
plaqu
burden
stenosi
sever
presenc
calcif
shown
influenc
peak
stress
clinic
studi
suggest
measur
peak
stress
may
improv
predict
futur
major
advers
cardiovascular
event
thu
highlight
clinic
need
prospect
quantifi
biomechan
stress
coronari
plaqu
tabl
tabl
mesh
gener
modal
solut
segment
plaqu
geometri
mesh
triangular
quadrilater
isoparametr
element
appropri
boundari
condit
wall
thick
mm
use
suppress
rigid
bodi
motion
radial
overstretch
arteri
respect
static
intralumin
pressur
kpa
appli
load
condit
mimic
physiolog
pressur
distribut
tensil
stress
comput
within
element
averag
stress
neighbor
element
calcul
obtain
tensil
stress
node
tensil
stress
distribut
similarli
calcul
node
within
coronari
cross
section
locat
maximum
tensil
stress
peak
stress
note
figur
figur
furthermor
thicker
nc
larg
nc
arc
elicit
high
peak
stress
also
observ
presenc
locat
thick
calcium
modul
peak
stress
observ
femderiv
peak
stress
fc
thick
best
fit
obtain
use
power
law
use
stepwis
multivari
regress
analysi
identifi
influenti
plaqu
paramet
exclud
redund
variabl
figur
tensil
stress
distribut
ncfa
particularli
peak
stress
fibrou
cap
crucial
predictor
plaqu
ruptur
major
advers
cardiovascular
event
patient
tradit
fem
model
approach
use
comput
peak
stress
mathemat
complex
requir
specialist
oper
take
hour
report
result
studi
key
find
studi
peak
stress
fibrou
cap
directli
estim
use
closedform
equat
equat
similar
studi
demonstr
nonlinear
relationship
figur
peak
stress
fc
thick
although
critic
fc
thick
mm
extens
report
publish
report
major
determin
plaqu
vulner
studi
demonstr
certain
condit
ncfa
thicker
fc
thick
similarli
exhibit
elev
peak
stress
observ
plaqu
thicker
cap
mm
peak
stress
minim
influenc
fc
thick
nc
thick
major
determin
psm
wherea
fc
thick
reduc
mm
peak
stress
exponenti
doradla
et
al
peak
stress
consider
elev
thin
calcif
nodul
cal
thick
mm
locat
vicin
lumen
callu
dist
mm
biomechan
studi
use
fem
indic
larg
variabl
peak
stress
valu
kpa
measur
ruptur
intact
coronari
plaqu
patient
studi
observ
peak
stress
valu
rang
kpa
even
tabl
studi
fem
use
pure
purpos
ncfa
figur
straightforward
mse
measur
observ
peak
stress
significantli
elev
vicin
ruptur
site
although
valid
prospect
clinic
test
warrant
initi
result
signific
indic
morphometr
measur
plaqu
geometri
may
accur
local
rupturepron
site
studi
limit
patient
cohort
investig
studi
ruptur
plaqu
observ
patient
therefor
mse
appli
identifi
ruptur
site
patient
patient
plaqu
ruptur
observ
maximum
psm
elev
close
site
plaqu
ruptur
figur
may
use
risk
measur
plaqu
destabil
ruptur
current
studi
doradla
et
al
valv
morpholog
later
studi
use
reveal
primari
mechan
mr
attribut
tether
mitral
valv
caus
dilat
lv
displac
papillari
muscl
rather
mitral
annular
dilat
anatom
mitral
leaflet
abl
cover
mitral
annulu
narrowest
portion
connect
la
lv
time
larger
leaflet
area
found
healthi
individu
tabl
thu
gener
mechan
patient
atrial
function
mr
somewhat
uncertain
although
case
posterior
leaflet
tether
encount
clinic
practic
accord
clinic
impress
posterior
leaflet
tether
rel
rare
subtyp
patient
atrial
function
mr
tend
observ
patient
extrem
advanc
la
remodel
fact
studi
report
atriogen
tether
main
mechan
atrial
function
mr
la
size
notabl
larger
studi
tabl
import
cosubstr
mitral
annulu
primarili
compos
fibrou
adipos
tissu
activ
contract
move
passiv
contract
la
muscular
lv
normal
mitral
annulu
known
saddl
shape
earli
systol
area
mitral
annulu
decreas
compar
diastol
saddl
shape
increas
depth
af
rhythm
immedi
blunt
motion
mitral
annulu
gradual
increas
size
flat
mitral
annulu
reduc
annular
contract
result
larger
systol
mitral
annulu
area
boost
annulu
area
leaflet
area
imbal
flatten
annulu
result
loss
deep
saddl
shape
caus
increas
stress
mitral
leaflet
greater
tether
distanc
regard
saddl
shape
studi
demonstr
significantli
higher
nonplanar
angl
flatten
annulu
patient
atrial
function
mr
studi
also
report
similar
annulu
height
without
atrial
function
mr
despit
larger
annulu
atrial
function
mr
suggest
flatten
annulu
present
patient
atrial
function
mr
thu
flatten
annulu
seem
pervas
well
total
studi
refer
preval
atrial
function
mr
patient
af
preserv
lv
function
figur
multivari
analysi
also
show
mr
signific
predictor
wors
outcom
hazard
ratio
confid
interv
therefor
comprehens
multiparametr
grade
recommend
novel
method
includ
vena
contracta
area
proxim
isoveloc
surfac
area
potenti
overcom
limit
regard
orific
shape
transesophag
echocardiographi
superior
imag
qualiti
enabl
detail
morpholog
assess
mitral
valv
apparatu
howev
mild
anesthesia
often
requir
discomfort
may
modifi
sever
function
mr
anoth
challeng
quantif
atrial
function
mr
beattobeat
variat
cycl
length
along
variabl
sever
mr
although
guidelin
recommend
quantif
use
averag
heart
beat
chamber
quantif
alway
easi
implement
recommend
clinic
practic
use
index
beat
whose
preced
prepreced
beat
rr
interv
may
effect
altern
control
therapi
af
particularli
paroxysm
af
late
scopeappl
cathet
ablat
expand
treat
perman
af
sever
studi
shown
cathet
ablat
superior
drug
therapi
maintain
sinu
rhythm
maze
procedur
better
freefromaf
surgic
treatment
may
current
reliabl
treatment
option
mr
atrial
function
af
smallsiz
studi
show
atrial
function
mr
control
surgic
annuloplasti
case
howev
annuloplasti
alon
may
alway
effect
figur
show
case
differ
anatom
characterist
mitral
valv
case
mr
primarili
attribut
insuffici
leaflet
remodel
small
mitral
leaflettoannulu
ratio
repair
replac
annual
tricuspid
regurgit
known
associ
signific
mortal
therefor
may
mani
patient
may
benefit
repairreplac
offer
surgeri
signific
morbid
mortal
less
invas
percutan
approach
could
highli
benefici
ventricl
potenti
complic
access
devic
deploymentfix
central
illustr
given
extrem
import
anatom
variabl
requir
detail
measur
specif
percutan
therapi
cta
critic
patient
assess
therefor
imag
qualiti
utmost
import
one
develop
challeng
need
anatom
screen
singl
patient
multipl
devic
given
valv
use
cta
without
know
devic
use
protocol
scan
given
devic
specif
anatom
consider
interact
broad
protocol
need
develop
institut
cover
potenti
devic
although
current
document
cover
consider
cardiac
cta
acquisit
plan
current
avail
studi
devic
adjust
need
made
protocol
devic
access
pathway
evolv
tmvr
optim
leftsid
opacif
necessari
case
devic
access
path
unknown
scan
trigger
valu
hu
though
toshiba
aquilion
one
famili
voic
trigger
hu
scan
trigger
valu
patient
bmi
kgm
younger
age
radiat
exposur
reduct
desir
consid
adjust
kv
possibl
recommend
use
automat
manual
select
experienc
oper
use
upper
end
rang
contrast
dose
earlier
gener
scanner
bmi
bodi
mass
index
cta
comput
tomographi
angiographi
hu
hounsfield
unit
abbrevi
tabl
use
toshiba
aquilion
one
famili
trigger
valu
voic
hu
scan
trigger
valu
possibl
recommend
use
automat
select
altern
optim
may
select
manual
experienc
oper
patient
bmi
kgm
younger
age
radiat
exposur
reduct
desir
consid
adjust
tube
potenti
kv
depend
scanner
kv
use
siemen
forc
maximum
tube
current
select
ml
protocol
earlier
gener
scanner
requir
longer
cardiac
scan
cover
cm
craniocaud
coverag
abbrevi
tabl
set
allow
ideal
homogen
mix
rightsid
contrast
imag
signific
streak
artifact
seen
right
heart
arrow
ra
right
atrium
rv
right
ventricl
abbrevi
figur
patient
contrast
enhanc
common
femor
vein
remain
within
peak
valu
attain
ct
pulmonari
angiogram
patient
within
peak
enhanc
ct
comput
tomographi
protocol
adjust
would
requir
either
reduc
inject
rate
ml
iodin
contrast
chang
mix
contrast
salin
approach
reduc
ad
delay
rather
tabl
tricuspid
protocol
ttvr
bolu
track
middl
right
ventricular
caviti
use
avoid
higher
chanc
streak
artifact
decreas
possibl
prematur
scan
limit
total
contrast
media
use
triphas
inject
recommend
use
mix
contrastsalin
approach
figur
use
hu
standard
trigger
threshold
valu
dilut
contrast
especi
ideal
rightsid
opacif
see
tabl
dilut
contrast
imag
focus
rightsid
cardiac
structur
arrhythmiatachycardia
tachycard
consist
beatsmin
gener
give
lowdos
metoprolol
diltiazem
depend
institut
approach
individu
patient
safeti
control
heart
rate
signific
fluctuat
rr
interv
although
tachycard
set
atrial
fibril
atrial
ventricular
arrhythmia
prolong
scan
exposur
full
rr
reconstruct
scanner
use
arrhythmia
edit
use
ignor
heart
rate
without
consider
rate
control
consid
adjust
scan
exposur
use
arrhythmia
edit
scanner
capabl
ct
comput
tomographi
fov
field
view
pvc
prematur
ventricular
contract
abbrevi
tabl
although
set
least
hu
precontrast
baselin
hounsfield
valu
ttvr
scan
rightsid
cardiac
structur
scan
monitor
delay
use
initi
bolu
track
venogram
need
part
tricuspid
protocol
vascular
access
possibl
includ
intern
jugular
subclavian
femor
vein
perform
nongat
mediumtohigh
pitch
helic
scan
neck
chest
abdomen
pelvi
extern
auditori
canal
lesser
trochant
venogram
scan
delay
cardiac
scan
use
allow
adequ
contrast
opacif
requir
venou
structur
experi
peak
femor
venou
opacif
quit
variabl
delay
cardiac
scan
select
goal
obtain
within
peak
venou
opacif
measur
hu
figur
situat
renal
impair
desir
limit
contrast
volum
total
ml
contrast
ml
tabl
could
use
slightli
adjust
recommend
protocol
elimin
second
contrastsalin
inject
annuloplasti
devic
implant
proxim
right
coronari
arteri
ct
protocol
trigger
thorac
aorta
reduc
scan
delay
use
faster
ml
flow
rate
ensur
adequ
right
coronari
right
heart
opacif
figur
modif
delay
venogram
scan
adjust
cardiac
scan
poor
renal
function
risk
contrastinduc
nephropathi
lower
total
iodin
administ
gener
decreas
total
contrast
volum
consid
perform
cardiac
vascular
scan
differ
day
although
necessari
rare
situat
concert
individu
inject
day
contrast
volum
reduct
perform
noncontrast
assess
andor
consid
altern
imag
modal
frequent
encount
patient
variabl
ie
low
cardiac
output
sever
valvular
heart
diseas
arrhythmia
sever
renal
impair
potenti
problem
recommendationstip
maxim
imag
qualiti
limit
patient
risk
increas
tube
current
result
linear
increas
radiat
exposur
increas
peak
tube
potenti
result
morethanlinear
increas
radiat
exposur
adapt
permiss
khaliqu
et
al
tabl
sever
challeng
aris
perform
special
scan
recommend
approach
avoid
suboptim
scan
offer
tabl
nt
format
sever
patientspecif
factor
need
taken
consider
may
modifi
particular
scan
protocol
specif
includ
patient
size
heart
size
cardiac
output
renal
function
heart
rate
rhythm
clinic
trial
begun
numer
transcathet
mitral
valv
tricuspid
valv
repair
replac
devic
cardiac
vascular
assess
transcathet
intervent
requir
highqual
anatomyspecif
ct
angiographi
protocol
mani
possibl
clinic
challeng
affect
ct
angiographi
review
specif
tip
troubleshoot
approach
provid
field
rapidli
advanc
requir
highqual
ct
angiographi
protocol
furthermor
recent
addit
highresolut
lge
imag
cmr
protocol
significantli
find
indic
holist
anatom
electroanatom
approach
key
allow
complet
identif
arrhythmogen
substrat
improv
select
ventricular
area
focu
map
final
better
local
target
ablat
site
ie
conduct
channel
entranc
although
crt
use
decad
bimod
distribut
pixel
intens
left
atrial
la
wall
normal
tissu
defin
first
mode
lower
pixel
intens
injur
tissu
n
sd
mean
pixel
intens
normal
tissu
histogram
pixel
intens
normal
tissu
defin
lower
region
pixel
intens
histogram
maximum
intens
within
la
wall
fibrot
threshold
calcul
sd
mean
normal
tissu
compar
analysi
preexist
fibrosi
assess
method
healthi
subject
magnet
reson
imag
process
addit
sd
mean
normal
myocardium
also
imag
intens
ratio
iir
techniqu
use
valid
cutoff
modifi
permiss
pontecorboli
et
al
imag
electrophysiolog
devic
implant
use
novel
strategi
combin
electr
mechan
strain
assess
may
particularli
suitabl
endocardi
pace
approach
abil
target
region
lv
endocardi
wall
without
constraint
coronari
venou
anatomi
recent
develop
wireless
intracardiac
lv
endocardi
electrod
crt
deliveri
repres
uniqu
opportun
use
integr
multimod
imag
guidanc
optim
lv
site
select
electrophysiologist
increasingli
reli
upon
cardiac
imag
diagnosi
treatment
manag
patient
variou
arrhythm
disord
integr
diagnost
intervent
cardiac
imag
increas
effect
cardiac
electrophysiolog
procedur
extens
use
cardiac
imag
help
deliv
patientspecif
therapi
ablat
cardiac
implant
electron
devic
imag
serv
ultim
goal
increas
effect
effici
electrophysiolog
procedur
intervent
well
deliv
patientspecif
therapi
cardiac
electrophysiolog
devic
indic
implant
lung
ultrasound
perform
peak
stress
show
develop
bline
interrog
lung
zone
bline
vertic
hyperecho
reverber
artifact
origin
pleural
line
yellow
arrow
stressinduc
bline
indic
thicken
lung
interstitium
correl
accumul
extravascular
lung
water
thu
mitral
valv
diseas
clearli
classifi
hemodynam
sever
sinc
exercis
mark
increas
left
atrial
pressur
lead
develop
acut
pulmonari
edema
increas
pulmonari
capillari
hydrostat
pressur
echocardiograph
find
high
transvalvular
mitral
gradient
mark
exerciseinduc
elev
right
ventricular
systol
pressur
confirm
diagnosi
ultim
patient
underw
mitral
valv
replac
follow
stress
test
see
video
wiley
et
al
patient
b
achiev
min
supin
bike
peak
heart
rate
bpm
agepredict
max
peak
transvalvular
mitral
gradient
mm
hg
regurgit
increas
moder
sever
qualit
assess
tricuspid
regurgit
doppler
envelop
incomplet
estim
least
ms
mm
hg
left
ventricular
eject
fraction
increas
mildli
shorten
ie
mcf
strain
disord
stroke
volum
markedli
reduc
howev
lvedv
also
reduc
calcul
ratio
stroke
volum
lvedv
ie
lvef
typic
fall
normal
nearnorm
rang
similar
discord
lvef
myocardi
shorten
seen
patient
heart
failur
preserv
eject
fraction
hfpef
context
chronic
system
inflammatori
metabol
disord
eg
obes
diabet
patient
inflammatori
chang
endothelium
coronari
microvasculatur
caus
microcirculatori
dysfunct
fibrosi
myocardium
impair
abil
left
ventricl
accommod
increas
chamber
volum
howev
central
blood
volum
often
elev
patient
result
sodium
retent
decreas
system
venou
capacit
consequ
stroke
volum
normal
mildli
increas
lvedv
also
normal
mildli
increas
lvef
ratio
stroke
volum
lvedv
measur
lvef
resid
normal
rang
yet
myocardi
contract
meaning
impair
inflammatori
fibrot
process
myocardium
serv
increas
myocardi
systol
perform
assess
quantifi
degre
myocardi
shorten
best
carri
measur
myocardi
strain
normal
observ
systol
eject
capac
myocardi
contract
ie
calcul
ratio
stroke
volum
myocardi
volum
measur
mcf
howev
current
wide
use
metric
systol
perform
normal
stroke
volum
lvedv
myocardi
volum
result
lvedv
markedli
enlarg
true
heart
microcirculatori
dysfunct
fibrosi
infiltr
hypertroph
process
rather
ventricular
remodel
enlarg
calcul
lvef
indic
systol
function
normal
fact
meaning
often
markedli
impair
circumst
measur
myocar
ing
given
similar
histopatholog
featur
diseas
knowledg
previous
describ
fabri
diseas
xlink
lysosom
storag
disord
caus
defici
agalactosidas
activ
character
progress
accumul
lysosom
glycosphingolipid
multipl
organ
includ
heart
mechan
toxic
like
relat
agent
may
help
prevent
earli
treatment
cancer
therapeuticsrel
cardiac
dysfunct
therefor
time
predict
cardiotox
could
signific
previou
systemat
review
describ
echocardiograph
myocardi
deform
paramet
cancer
chemotherapi
comparison
includ
prospect
studi
focus
predict
accuraci
pool
estim
best
knowledg
studi
first
metaanalysi
figur
eat
bmi
appear
independ
predictor
mace
day
patient
undergo
elect
noncardiac
surgeri
appear
increment
rcri
coronari
cta
cac
patient
without
gout
gout
also
associ
higher
serum
uric
acid
mgdl
iqi
mgdl
vs
mgdl
iqi
mgdl
p
mace
occur
patient
gout
goutfre
patient
figur
patient
stratifi
cac
gout
associ
increas
annual
mace
high
cac
though
median
cac
significantli
increas
gout
categori
figur
best
knowledg
first
studi
systemat
report
alter
cardiac
pleas
note
dr
petersen
neubauer
piechnik
acknowledg
british
heart
foundat
fund
manual
analysi
creat
cardiovascular
magnet
reson
imag
refer
standard
uk
biobank
imag
resourc
cardiovascular
magnet
reson
scan
wwwbhforguk
dr
aung
support
wellcom
trust
research
train
fellowship
wellcomeacuk
dr
fung
support
medic
colleg
saint
bartholomew
hospit
trust
independ
regist
chariti
promot
advanc
medic
dental
educ
research
bart
london
school
medicin
dentistri
dr
piechnik
receiv
support
nation
institut
health
research
nihr
cardiovascular
biomed
research
centr
bart
dr
piechnik
lee
receiv
support
smartheart
engin
physic
scienc
research
council
epsrc
programm
grant
wwwnihracuk
dr
jensen
support
danish
heart
foundat
danish
societi
cardiolog
dr
neubauer
piechnik
receiv
support
oxford
nation
institut
health
research
biomed
research
centr
oxford
british
heart
foundat
centr
research
excel
project
enabl
access
medic
research
council
mrc
emedlab
medic
bioinformat
infrastructur
support
medic
research
council
funder
provid
support
form
salari
author
detail
addit
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
dr
petersen
provid
consult
circl
cardiovascular
imag
inc
calgari
canada
servier
dr
jensen
serv
consult
advisori
board
invit
speaker
astrazeneca
novo
nordisk
novarti
ge
author
report
relationship
relev
content
paper
disclos
assum
observ
overal
complic
rate
sampl
size
studi
differ
complic
rate
ie
vs
larger
could
detect
power
type
error
procedur
complic
occur
less
often
women
ct
group
compar
ica
group
ct
vs
ica
procedur
complic
similar
men
group
ct
vs
ica
major
procedur
complic
uncommon
ct
ica
group
sex
tabl
minor
procedur
complic
occur
less
often
women
ct
group
compar
ica
group
tabl
interact
sex
studi
arm
regard
procedur
complic
p
number
event
longterm
followup
year
similar
women
men
group
tabl
studi
limit
singlecent
design
small
total
number
advers
event
although
earlier
studi
reveal
differ
women
men
regard
preval
symptom
cad
first
studi
analyz
sex
differ
term
outcom
diagnost
procedur
ct
ica
studi
show
women
atyp
chest
pain
clinic
indic
coronari
evalu
may
benefit
strategi
base
ct
instead
ica
specif
due
reduct
minor
procedur
complic
possibl
reason
result
lower
pretest
probabl
diseas
men
lower
rate
complex
diseas
women
expect
benefit
less
initi
ica
women
obstruct
cad
comorbid
present
atyp
symptom
tend
letter
editor
valu
n
signific
bonferroni
correct
factor
test
subgroup
ct
comput
tomographi
ica
invas
coronari
angiographi
although
investig
mention
nonlbbb
separ
data
popul
nonlbbb
report
studi
import
controversi
crt
benefit
nonlbbb
andor
right
bundl
branch
block
also
receiveroper
characterist
analysi
report
absenc
noncrt
control
group
crt
respons
probabl
continu
relat
ssi
clinician
may
specul
ad
valu
ssi
ssi
threshold
use
cardiolog
practic
low
ssi
valu
may
preclud
patient
treat
crt
final
common
observ
studi
crt
respons
associ
echodyssynchroni
measur
irrespect
presenc
lbbb
mean
echocardiographi
take
back
control
select
crt
candid
discredit
decad
ago
imag
subsequ
ct
cmr
cmr
studi
also
show
quantit
might
also
allow
differenti
epicardi
cad
microvascular
diseas
quantit
perfus
also
found
role
prognost
multipl
modal
spect
pet
evid
lack
contemporari
data
risk
stratif
incred
import
given
evid
declin
risk
symptomat
patient
cohort
manifest
reduc
rate
ischemia
obstruct
coronari
arteri
diseas
high
predict
accuraci
present
spect
find
provid
novel
evid
modal
continu
highli
predict
cardiac
risk
statement
import
vital
messag
registri
quantit
complementari
refin
risk
estim
larg
patient
cohort
fact
patient
normal
visual
read
annual
event
rate
rang
consider
stress
total
perfus
deficit
quantifi
automat
myocardium
similar
stratif
also
report
patient
sum
stress
score
data
support
import
stratif
risk
date
appreci
nuclear
interpret
find
signific
recent
trial
evid
report
patient
lower
risk
find
see
new
emerg
evid
support
util
nuclear
cardiolog
especi
excit
age
big
data
machin
learn
let
us
also
hope
unfold
data
random
trial
compar
effect
cardiac
magnet
reson
coronari
comput
tomograph
angiographi
also
see
growth
use
cardiac
pet
would
fundament
optim
patient
care
trial
evid
support
superior
accuraci
improv
clinic
outcom
compar
competit
modal
includ
spect
far
challeng
nuclear
commun
rais
bar
new
level
